HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PCPC Hatching Proposal For CIR Role In FDA Ingredient Review

This article was originally published in The Rose Sheet

Executive Summary

The Personal Care Products Council has a vision for marrying the Cosmetic Ingredient Review’s expertise with FDA’s authority, which it hopes to package into reform legislation expected this year. While FDA has balked at formalizing CIR’s role under previous proposals, this one was inspired by a third-party review program for medical devices, making it potentially more palatable to the agency and lawmakers.

Advertisement

Related Content

Senate Health Committee Releases Cosmetics Reform Discussion Draft
Surprise Hatch Bill Lays Middle Ground For Cosmetic Regulatory Reform
Cosmetics Reform Bill Relaunches In Senate, Sending Stakeholders To Familiar Corners
CIR Director Gill Steps Down, Leaving Legacy Of Improved Transparency
Cosmetics Stakeholders Race To Hitch Reform Provisions To FDA User-Fee Bills
PCPC Statement On Cosmetics Reform Legislation Hints At Potential Compromises
House Cosmetics Bill Reintroduced; ICMAD Optimistic In New Political Climate
FDA Questions Constitutionality Of Proposed CIR Bridge, A Blow To CMA Bill
Cosmetic Ingredient Use Under Feinstein Bill; Where Does CIR Come In?

Topics

Advertisement
UsernamePublicRestriction

Register

RS109123

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel